Expanding scope of TEMRA in autoimmunity

Affiliations

¹ Departments of Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, College of Medicine, Syracuse, NY, 13210, USA.
² Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, TX, 78229-3900, USA. Electronic address: morel@uthscsa.edu.

Andras Perl et al. EBioMedicine. 2023 Apr.

. 2023 Apr:90:104520.

doi: 10.1016/j.ebiom.2023.104520. Epub 2023 Mar 10.

¹ Departments of Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, College of Medicine, Syracuse, NY, 13210, USA.
² Department of Microbiology, Immunology, and Molecular Genetics, University of Texas Health San Antonio, TX, 78229-3900, USA. Electronic address: morel@uthscsa.edu.

No abstract available

Conflict of interest statement

Declaration of interests The authors declare no conflict of interest.

1. Li H., Tsokos G.C. Double-negative T cells in autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):163–172. - PMC - PubMed
1. McKinney E.F., Lee J.C., Jayne D.R.W., Lyons P.A., Smith K.G.C. T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature. 2015;523(7562):612–616. - PMC - PubMed
1. Chen P.M., Katsuyama E., Satyam A., et al. CD38 reduces mitochondrial fitness and cytotoxic T cell response against viral infection in lupus patients by suppressing mitophagy. Sci Adv. 2022;8(24) - PMC - PubMed
1. Xiong H., Cui M., Kong N., et al. Cytotoxic CD161-CD8+ TEMRA cells contribute to the pathogenesis of systemic lupus erythematosus. eBioMedicine. 2023 doi: 10.1016/j.ebiom.2023.104507. - DOI - PMC - PubMed
1. Lai Z.W., Kelly R., Winans T., et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial. Lancet. 2018;391(10126):1186–1196. - PMC - PubMed